Editing Acetyl L-carnitine (ALCAR)

Jump to: navigation, search

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision Your text
Line 19: Line 19:
  
 
It has been concluded to have a great potential for the treatment of diabetic neuropathy. {{#pmid:9864270|nakamura1998}}
 
It has been concluded to have a great potential for the treatment of diabetic neuropathy. {{#pmid:9864270|nakamura1998}}
 
Serum levels of L-carnitine are lower in patients with ALS in comparison to healthy people. Also, the lower serum level of L-carnitine is associated with the higher severity of the disease. {{#pmid:34119273|sarraf2021}}
 
  
 
=== Regulated pathways ===
 
=== Regulated pathways ===
Line 29: Line 27:
  
 
In a 1989 study on four autopsied ALS patients and four controls, the average ChAT activity, expressed on a dry weight basis, of 58 ALS neurons was lower than that of 67 control neurons. The large, well-preserved neurons at the early nonadvanced stage had markedly lower ChAT activities than control neurons. {{#pmid:2911033|kato1989}}
 
In a 1989 study on four autopsied ALS patients and four controls, the average ChAT activity, expressed on a dry weight basis, of 58 ALS neurons was lower than that of 67 control neurons. The large, well-preserved neurons at the early nonadvanced stage had markedly lower ChAT activities than control neurons. {{#pmid:2911033|kato1989}}
 +
 +
 +
 +
  
 
== Discussion threads on the ALSTDI forum ==
 
== Discussion threads on the ALSTDI forum ==
Line 40: Line 42:
 
[http://www.alstdi.org/forum/yaf_postst52472_lcarnitine-no-followup.aspx L-carnitine: no follow-up?]
 
[http://www.alstdi.org/forum/yaf_postst52472_lcarnitine-no-followup.aspx L-carnitine: no follow-up?]
 
:L-Carnitine without the acyl group may be better at targeting muscles and NMJ:s and has better bioavailability, whereas Acetyl L-carnitine is able to cross the blood-CNS-boundary and reach glia and neurons.
 
:L-Carnitine without the acyl group may be better at targeting muscles and NMJ:s and has better bioavailability, whereas Acetyl L-carnitine is able to cross the blood-CNS-boundary and reach glia and neurons.
 +
  
 
== Pubmed link collection at Studies on ALS ==
 
== Pubmed link collection at Studies on ALS ==

Please note that all contributions to MyWiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see MyWiki:Copyrights for details). Do not submit copyrighted work without permission!

To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:

Cancel | Editing help (opens in new window)

Template used on this page: